Xiuman Zhou

机构：Sun Yat-sen University, The Seventh Affiliated Hospital of Sun Yat-sen University, Center for Digestive and Liver Diseases, Colorado Kidney Care · ORCID：0000-0002-5938-450X

发表论文 70 篇 · 总被引 2408 次 · h-index 27

代表论文

• A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy (2025 · Nature Communications · 被引 80)
• Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy (2024 · Journal of Controlled Release · 被引 43)
• Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy (2023 · Journal of Controlled Release · 被引 35)
• Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy (2023 · Acta Pharmaceutica Sinica B · 被引 31)
• Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy (2024 · Cell Communication and Signaling · 被引 27)
• Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy (2024 · Science China Life Sciences · 被引 27)